MA
BIOA

MYDA Advisors’s BioAge Labs BIOA Stock Holding History

MYDA Advisors’s Portfolio BIOA Stock Details BIOA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-30,000
Closed -$174K – 198
2024
Q4 		$174K Buy
+30,000
New +$517K 0.04% 125

Other funds holding BIOA

ACM
AH Capital Management Menlo Park, California $1.29B AUM 26.81% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $2.63B AUM 117.41% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $1.7B AUM 340.85% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
SCV
Sands Capital Ventures Arlington, Virginia $421M AUM 26.25% 1-Year Est. Return

MYDA Advisors's BIOA Position: Q1 2025 in Review

MYDA Advisors sold out of BioAge Labs (BIOA) in Q1 2025, closing a stake of 30,000 shares — an estimated $174K sold.

MYDA Advisors first reported a position in BIOA in Q4 2024 and held it in 1 quarter. The position peaked at $174K in Q4 2024. 67 funds tracked by Wall St. Rank hold BIOA as of Q1 2025.

  • MYDA Advisors reported no remaining BioAge Labs position as of Q1 2025 after selling out during the quarter.
  • MYDA Advisors sold 30,000 BioAge Labs shares in Q1 2025, an estimated $174K.
  • MYDA Advisors first reported a position in BioAge Labs in Q4 2024 and held it in 1 quarter.
  • MYDA Advisors's BioAge Labs position peaked at $174K in Q4 2024.
  • 67 funds tracked by Wall St. Rank held BioAge Labs as of Q1 2025.

Based on MYDA Advisors's 13F filing for Q1 2025, filed 14 May 2025.